Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/12/02–25/12/04 | 25/12/04 | 350,000 sh3 trades | $1.44avg. | $503,000 | +0.5% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/24–25/11/25 | 25/11/26 | 7,700,000 sh2 trades | $1.30avg. | $10,029,500 | +12.0% | |
Standard BiotoolsLAB | Open-market buy | 25/11/18–25/11/20 | 25/11/20 | 1,075,000 sh3 trades | $1.28avg. | $1,371,250 | +1.7% | |
Standard BiotoolsLAB | Open-market buy | 25/11/18–25/11/20 | 25/11/20 | 1,075,000 sh3 trades | $1.28avg. | $1,371,250 | +1.7% | |
Standard BiotoolsLAB | Open-market buy | 25/11/18–25/11/20 | 25/11/20 | 1,075,000 sh3 trades | $1.28avg. | $1,371,250 | +1.7% | |
Standard BiotoolsLAB | Open-market buy | 25/11/18–25/11/20 | 25/11/20 | 1,075,000 sh3 trades | $1.28avg. | $1,371,250 | +1.7% |